MARKET

CDXS

CDXS

Codexis
NASDAQ

Real-time Quotes | Nasdaq Last Sale

19.41
-0.60
-3.00%
Opening 14:28 03/05 EST
OPEN
20.41
PREV CLOSE
20.01
HIGH
20.45
LOW
18.28
VOLUME
734.53K
TURNOVER
--
52 WEEK HIGH
29.56
52 WEEK LOW
8.43
MARKET CAP
1.25B
P/E (TTM)
-47.8668
1D
5D
1M
3M
1Y
5Y
In-vitro Diagnostics Enzymes Market Size Is Projected To Surpass US$ 97.0 Billion By 2026
Mar 05, 2021 (Market Insight Reports) -- A recent report provides crucial insights along with application based and forecast information in the Global...
Market Insight Reports · 10h ago
Enzymes Market To Grow At A Remarkable Pace Owing To The Launch Of Articzymes’s First Ligase Enzyme | Fortune Business Insights
Mar 05, 2021 (The Expresswire) -- The increasing demand for enzymes as pharmaceutical products is driving the global enzymes market, says Fortune Business...
The Express Wire · 14h ago
Industrial Enzymes Market Share, Development by Companies Outlook, Growth Prospects and Key Opportunities by 2030
Heraldkeepers · 1d ago
Global Air Pollution Control System for Coal-fired Power Plants Market Size 2021 - Upcoming Scope, Size Estimation, Returns, Pricing Trends, Growth Opportunity, Regional Outlook and Forecast to 2026
The Express Wire · 2d ago
10-K: CODEXIS, INC.
(EDGAR Online via COMTEX) -- ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and...
Edgar Online - (EDG = 10Q, 10K) · 3d ago
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2021
Benzinga · 4d ago
DJ Codexis Initiated at Buy by Stifel
Dow Jones · 4d ago
DJ Codexis Price Target Announced at $30.00/Share by Stifel
Dow Jones · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CDXS. Analyze the recent business situations of Codexis through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CDXS stock price target is 26.86 with a high estimate of 30.00 and a low estimate of 23.00.
EPS
Institutional Holdings
Institutions: 222
Institutional Holdings: 61.60M
% Owned: 96.98%
Shares Outstanding: 64.40M
TypeInstitutionsShares
Increased
46
7.05M
New
43
2.80M
Decreased
46
3.10M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.19%
Pharmaceuticals & Medical Research
+0.84%
Key Executives
Chairman/Independent Director
Bernard Kelley
President/Chief Executive Officer/Director
John Nicols
Chief Financial Officer/Senior Vice President
Ross Taylor
Senior Vice President
Laurie Heilmann
Independent Director
Jennifer Aaker
Independent Director
Thomas Baruch
Independent Director
Pam Cheng
Independent Director
Byron Dorgan
Director
Patrick Y. Yang
Independent Director
Esther Martinborough
Independent Director
David Smith
Independent Director
Dennis Wolf
Independent Director
Patrick Yang
No Data
About CDXS
Codexis, Inc. is a protein engineering company. The Company is engaged in the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. The Company operates through its two segments, such as the performance enzymes and novel biotherapeutics. It provides enzyme optimization services from small scale through to commercial quantities and also develops biocatalyst products. It is also engaged in the development of manufacturing processes for active pharmaceutical ingredients, fine chemicals and food ingredients. Its CodeEvolver is a protein engineering technology platform and products in the pharmaceuticals market. The Company serves various industries, including food and food ingredients, animal feed, flavors, fragrances, and agricultural chemical.

Webull offers kinds of Codexis, Inc. stock information, including NASDAQ:CDXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CDXS stock methods without spending real money on the virtual paper trading platform.